Associate Professor Maciej Wybraniec
School of Medicine in Katowice, Medical University of Silesia, Katowice (Poland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study
Event: ESC Congress 2023
Topic: Antiarrhythmic Drug Treatment
Session: Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation
Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis
Event: ESC Congress 2023
Topic: Complications
Session: Coronary diagnostics and interventions
Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry
Event: ESC Congress 2022
Topic: Oral Anticoagulation
Session: Stroke prevention in atrial fibrillation
Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study
Event: ESC Congress 2021 - The Digital Experience
Topic: Rhythm Control, Cardioversion
Session: Atrial fibrillation e-posters
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
Event: ESC Congress 2021 - The Digital Experience
Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease
Session: Cardiovascular Disease in Special Populations ePosters
Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study
Event: ESC Congress 2020
Topic: Rhythm Control, Cardioversion
Session: Atrial Fibrillation ePosters
Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis
Event: ESC Congress 2019
Topic: Secondary Prevention
Session: Risk factors and prevention
Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.
Event: ESC Congress 2019
Topic: Secondary Prevention
Session: Risk factors and prevention
Propensity score matched analysis of antazoline mesylate vs. amiodarone or propafenone for pharmacological cardioversion of short-duration atrial fibrillation
Event: ESC Congress 2019
Topic: Rhythm Control, Cardioversion
Session: Drug treatment for atrial fibrillation
Renal resistive index is associated with adverse cardiovascular events at 24 months in patients with coronary artery disease submitted to coronary angiography
Event: ESC Congress 2018
Topic: Noninvasive Diagnostic Methods
Session: Coronary artery disease : diagnosis pharmacotherapy and revascularisation
ESC 365 is supported by
